EUVIMEDEUVIMED entdecken
Vergleichsstudie

Two Decades of Progress and Remaining Challenges: Comparative Analysis of Rare Disease Policy Implementation in Bulgaria, Romania, and Greece

Iva Nenkova iD, Petya Pavlikyanova, Adina Turcu-Stiolica, Mihaela-Simona Naidin, Athanasios Margetis, Stanislava Yordanova, Assena Serbezova, Maria Kamusheva

Therapeutic Innovation & Regulatory Science · 2026-11 · 60 (6) · 1710-1719

DOI: 10.1007/s43441-026-01019-6 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Therapeutic Innovation & Regulatory Science, online erschienen am 11.07.2026. Verfasst von Iva Nenkova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department "Organisation and economics of pharmacy", Faculty of Pharmacy, Medical University-Sofia, Sofia, Bulgaria. iva.krasimirovaa@gmail.com. Hauptthemen laut MEDLINE: Rare Diseases, Health Policy. Die Arbeit nennt 52 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Rare diseases (RDs) pose significant challenges to public health, affecting millions of individuals across the world. Since the adoption of Regulation (EC) No. 141/2000, the European Union (EU) has provided a unified framework for national RD policies. This study provides an overview of RDs legislation over the past two decades (2000-2024), with a comparative analysis of the period 2012-2024 in three neighbouring EU Member States: Bulgaria, Romania, and Greece. The analysis focuses on legal frameworks, national strategies, centres of expertise (CEs), and disease registries. RESULTS: All three countries have developed RD-related policy structures aligned with EU standards; however, important differences remain in their level of institutionalisation, coordination, and implementation. Bulgaria demonstrates a more formalised organisational framework through the early adoption of a dedicated National Rare Disease Programme (NRDP), an official RD list, and formal coordination mechanisms, alongside the expansion of CEs, disease registries, and neonatal screening. In contrast, Romania and Greece lack updated standalone NRDPs, with Romania integrating RD policies within broader national health strategies and Greece relying more on fragmented initiatives and broader healthcare reforms. While CEs, registries, and neonatal screening programmes are present across all three countries, differences persist in their organisation, national coordination, and degree of integration. Overall, the existence of policy frameworks and organisational structures does not necessarily indicate their effective implementation, integration, or equitable patient access. CONCLUSIONS: RD policy frameworks in Bulgaria, Romania, and Greece have developed over the past two decades, reflecting progressive alignment with EU-level recommendations. However, implementation remains uneven, fragmented, and differently organised across the three countries. These findings suggest that legislative harmonisation alone is insufficient to ensure coordinated and effective RD policy implementation. Future research is needed to examine how these structures function in practice and whether they improve healthcare delivery, care coordination, and patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rare DiseasesHealth PolicyBulgariaHumansRomaniaGreeceEuropean UnionRegistries

Stichwörter der Autor:innen

Balkan regionEuropean UnionHealthcare policyLegislationOrphan medicinal productsRare diseases

Autor:innen und Institutionen

  • Department "Organisation and economics of pharmacy", Faculty of Pharmacy, Medical University-Sofia, Sofia, Bulgaria. iva.krasimirovaa@gmail.com.
  • Department "Organisation and economics of pharmacy", Faculty of Pharmacy, Medical University-Sofia, Sofia, Bulgaria.
  • Department of Pharmaceutical management and marketing, Faculty of Pharmacy, University of Medicine and Pharmacy of Craiova, Craiova, Romania.
  • Health Technology Assessment and Reimbursement Committee, Greek Ministry of Health, Athens, Greece.
  • Community pharmacist, Sofia, Bulgaria.
  • Faculty of Public Health, Medical University-Sofia, Sofia, Bulgaria.

ORCID-Profile: Iva Nenkova

Zitieren

APA

Nenkova, I., Pavlikyanova, P., Turcu-Stiolica, A., Naidin, M. S., Margetis, A., Yordanova, S., Serbezova, A., & Kamusheva, M. (2026). Two Decades of Progress and Remaining Challenges: Comparative Analysis of Rare Disease Policy Implementation in Bulgaria, Romania, and Greece. Therapeutic Innovation & Regulatory Science, 60(6), 1710-1719. https://doi.org/10.1007/s43441-026-01019-6

Vancouver

Nenkova I, Pavlikyanova P, Turcu-Stiolica A, Naidin MS, Margetis A, Yordanova S, et al. Two Decades of Progress and Remaining Challenges: Comparative Analysis of Rare Disease Policy Implementation in Bulgaria, Romania, and Greece. Therapeutic Innovation & Regulatory Science. 2026;60(6):1710-1719. doi:10.1007/s43441-026-01019-6

BibTeX
@article{Nenkova2026,
  author = {Nenkova, Iva and Pavlikyanova, Petya and Turcu-Stiolica, Adina and Naidin, Mihaela-Simona and Margetis, Athanasios and Yordanova, Stanislava and Serbezova, Assena and Kamusheva, Maria},
  title = {Two Decades of Progress and Remaining Challenges: Comparative Analysis of Rare Disease Policy Implementation in Bulgaria, Romania, and Greece},
  journal = {Therapeutic Innovation & Regulatory Science},
  year = {2026},
  volume = {60},
  number = {6},
  pages = {1710--1719},
  doi = {10.1007/s43441-026-01019-6}
}
Kostenlos starten →